BVMF/U2TH34 (BVMF/U2TH34)

Brazil Stock Exchange: BVMF/U2TH34 · BRL

R$157

-5.40 (-3.3%)· Recorded snapshot

Market cap	137.8B
Revenue (ttm)	16.3B
Net income (ttm)	6.8B
EPS (ttm)	R$7.52
P/E (trailing)	20.9x
P/E (forward)	18.5x
Volume	200
Beta	0.49

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16.3B
Net income (ttm): 6.8B
EPS (ttm): R$7.52
P/E (trailing): 20.9x
P/E (forward): 18.5x
Market cap: 137.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E18.5

P25 n/aP50 n/aP75 n/a

Trailing P/E20.9

P25 n/aP50 n/aP75 n/a

ROE19.3

P25 n/aP50 n/aP75 n/a

ROIC31.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/U2TH34 indicators

Market & fundamental data

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-04
Employees	1,400
Employees change	95
Employees growth	7.28%
Enterprise value	BRL 117.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	BRU2THBDR002
Last earnings date	2026-08-05
Last refreshed	2026-10-30
Market cap	BRL 137.8B
Next earnings date	2026-11-04
Price	BRL 157.10
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bvmf/U2TH34
Website	https://www.unither.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	12.96x
Average P/E ratio (3Y)	13.63x
Average P/E ratio (5Y)	14.38x
Earnings yield	4.79%
EV/Earnings	17.26x
EV/EBIT	15.42x
EV/EBITDA	14.39x
EV/FCF	20.7x
EV/Sales	6.86x
FCF / EV yield	4.83%
FCF yield	4.11%
Forward P/E	18.49x
Graham number	81.15929
Graham upside	-48.34%
Lynch fair value	BRL 175.96
Lynch upside	12%
P/(FCF - SBC) ratio	28.37x
P/(OCF - SBC) ratio	17.39x
P/B ratio	4.16x
P/E ratio	20.9x
P/FCF ratio	24.33x
P/OCF ratio	15.78x
P/S ratio	8.43x
Price / tangible book value	4.23x
Price/EBITDA ratio	17.78x
Sector forward P/E	10.79x
Sector P/E	32.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	44.53%
EBITDA margin	47.43%
Effective tax rate	16.66%
FCF margin	33.36%
Gross margin	86.14%
Operating margin	44.53%
Pretax margin	49.87%
Profit margin	41.56%
Profit per employee	BRL 4.9M
Profitable quarters	29
Profitable years	6
Revenue per employee	BRL 11.7M
ROA	11.61%
ROA (5Y)	11.19%
ROCE	21.24%
ROE	19.32%
ROE (5Y)	17.35%
ROIC	31.28%
ROIC (5Y)	27.79%
SBC / revenue	4.93%
Tax / revenue	8.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.04%
EPS growth (Q)	13.42%
EPS growth (QoQ)	24.91%
EPS growth 10Y	3.05%
EPS growth 3Y	16.53%
EPS growth 5Y	22.22%
EPS growth quarters	1
EPS growth years	4
FCF growth	2.05%
FCF growth (Q)	58.76%
FCF growth (QoQ)	-43.28%
FCF growth 3Y	17.51%
FCF growth 5Y	14.31%
Gross profit growth	-0.78%
Gross profit growth (Q)	-3.83%
Gross profit growth 3Y	12.7%
Gross profit growth 5Y	13.05%
Net income growth	5.54%
Net income growth (Q)	7.59%
Net income growth (QoQ)	21.13%
Net income growth 3Y	14.58%
Net income growth 5Y	22.72%
Net income growth quarters	1
Net income growth years	4
OCF growth	22.89%
OCF growth (Q)	63.59%
OCF growth (QoQ)	-32.31%
OCF growth 10Y	13.28%
OCF growth 3Y	24.76%
OCF growth 5Y	22.33%
Operating income growth	-9.04%
Operating income growth (Q)	-14.34%
Operating income growth 3Y	8.59%
Operating income growth 5Y	19.32%
Revenue growth	2.49%
Revenue growth (Q)	-1.92%
Revenue growth (QoQ)	0.23%
Revenue growth 10Y	7.21%
Revenue growth 3Y	14.33%
Revenue growth 5Y	14.68%
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -3.1B
Depreciation and amortization	BRL 492.3M
EBIT	BRL 7.3B
EBITDA	BRL 7.8B
EPS	BRL 7.52
Financing cash flow	BRL -11.5B
Free cash flow	BRL 5.7B
Free cash flow minus SBC	BRL 4.9B
Gross profit	BRL 14.1B
Income taxes	BRL 1.4B
Investing cash flow	BRL 3.9B
Net cash flow	BRL 1.1B
Net income	BRL 6.8B
Operating cash flow minus SBC	BRL 7.9B
Operating income	BRL 7.3B
Revenue	BRL 16.3B
Stock-based compensation	BRL 805.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	18.19
Book value per share	BRL 776.97
Debt / equity	0
Interest coverage	117.06
Long-term assets	BRL 18.7B
Long-term liabilities	BRL 977.1M
Net cash (debt)	BRL 19.7B
Net cash / market cap	14.3%
Net cash growth	-23.42%
Net debt / EBITDA	-2.54
Net debt / equity	-0.59
Net debt / FCF	-3.48
Piotroski F-Score	4
Property, plant and equipment	BRL 10.4B
Shareholders' equity	BRL 33.2B
Tangible book value	BRL 32.6B
Tangible book value per share	BRL 763.12
Total assets	BRL 37.4B
Total cash	BRL 13.8B
Total debt	BRL 0
Total liabilities	BRL 4.2B
WACC	6.95%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	BRL 18.7B
Current liabilities	BRL 3.3B
Current ratio	5.73
Inventory turnover	2.41
Net working capital	BRL 1.1B
Quick ratio	4.89
Working capital	BRL 14.9B
Working capital turnover	5.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.2%
Shareholder yield	3.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 114.83
1D price change	-3.32%
1M price change	23.7%
1M total return	23.7%
1W price change	8.2%
1W total return	8.2%
1Y price change	38.26%
1Y return CAGR	38.29%
1Y total return	38.26%
20-day SMA	BRL 138.34
3M price change	19.02%
3M total return	19.02%
50-day SMA	BRL 135.18
52-week high	BRL 162.50
52-week high date	2026-10-26
52-week low	BRL 119.64
52-week low date	2026-02-23
6M price change	2.23%
6M total return	2.23%
All-time high	BRL 162.50
All-time high date	2026-10-26
All-time low	BRL 54.20
All-time low date	2024-01-24
Average true range (ATR)	BRL 5.25
Average volume	587.9
Beta (5Y)	0.49
Change from 52-week high	-3.32%
Change from 52-week low	31.31%
Change from all-time high	-3.32%
Change from all-time low	189.85%
Change from open	0%
Day's gap	-3.32%
Dollar volume	BRL 31,420
High price	BRL 157.10
Low price	BRL 157.10
Monthly RSI	71.57
Open price	BRL 157.10
Previous close	BRL 162.50
Price vs 150-day SMA	36.81%
Price vs 20-day SMA	13.56%
Price vs 50-day SMA	16.22%
Relative volume	0.34
RSI	64.11
Sharpe ratio	2.03
Sortino ratio	4.63
Volume	200
Weekly RSI	70.34
YTD price change	15.52%
YTD total return	15.52%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39.2M
Shares change (QoQ)	-2.97%
Shares change (YoY)	-3.2%
Shares held by insiders	1.95%
Shares held by institutions	92.76%
Short ratio	3.4 days

Deeper analysis on BVMF/U2TH34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/U2TH34 report

Is a complete BVMF/U2TH34 research report available?

No complete published report is available for bvmf/U2TH34 (BVMF/U2TH34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/U2TH34 (BVMF/U2TH34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/U2TH34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/U2TH34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/U2TH34

Frequently asked questions